Loading...
OTCM
CMPUY
Market cap677mUSD
May 07, Last price  
24.63USD
Name

CompuGroup Medical SE & Co KgaA

Chart & Performance

D1W1MN
P/E
17.35
P/S
0.52
EPS
1.26
Div Yield, %
4.71%
Shrs. gr., 5y
1.33%
Rev. gr., 5y
9.12%
Revenues
1.15b
-2.84%
5,852,700180,189,000229,191,000300,288,000319,367,000396,564,000450,582,000459,554,000515,104,000543,066,000560,195,000582,375,000717,023,000745,808,000837,259,0001,025,322,0001,129,739,0001,187,663,0001,153,987,000
Net income
35m
-24.65%
5,844,38123,032,0001,268,00011,716,00016,593,0009,271,00030,716,00023,147,00026,337,00038,494,00044,530,00031,250,00092,338,00065,819,00073,192,00068,970,00073,411,00045,916,00034,600,000
CFO
129m
-28.21%
16,502,00025,191,00025,912,00044,004,00040,378,00046,736,00066,905,00052,331,00031,940,00073,247,00067,613,00085,823,000136,348,000110,495,000149,931,000165,274,000145,027,000179,528,000128,882,000
Dividend
May 23, 20241.16063 USD/sh
Earnings
Jul 14, 2025

Profile

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
IPO date
May 04, 2007
Employees
8,954
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,153,987
-2.84%
1,187,663
5.13%
1,129,739
10.18%
Cost of revenue
223,611
246,616
322,750
Unusual Expense (Income)
NOPBT
930,376
941,047
806,989
NOPBT Margin
80.62%
79.24%
71.43%
Operating Taxes
27,133
25,800
32,699
Tax Rate
2.92%
2.74%
4.05%
NOPAT
903,243
915,247
774,290
Net income
34,600
-24.65%
45,916
-37.45%
73,411
6.44%
Dividends
(51,735)
(26,117)
(26,117)
Dividend yield
Proceeds from repurchase of equity
(14,642)
305,361
BB yield
Debt
Debt current
53,553
25,858
53,301
Long-term debt
880,893
797,519
786,509
Deferred revenue
3,353
15,529
Other long-term liabilities
57,496
142,760
38,237
Net debt
817,382
726,116
738,802
Cash flow
Cash from operating activities
128,882
179,528
145,027
CAPEX
(63,226)
(18,973)
(81,038)
Cash from investing activities
(105,281)
(124,327)
(145,414)
Cash from financing activities
18,813
(80,687)
(16,359)
FCF
878,703
884,856
763,780
Balance
Cash
107,605
64,557
91,013
Long term investments
9,459
32,704
9,995
Excess cash
59,365
37,878
44,521
Stockholders' equity
54,131
55,329
779,028
Invested Capital
1,535,020
1,541,096
1,416,498
ROIC
58.73%
61.89%
56.93%
ROCE
55.12%
59.60%
51.43%
EV
Common stock shares outstanding
52,785
52,455
52,289
Price
Market cap
EV
EBITDA
1,042,025
1,056,845
919,310
EV/EBITDA
Interest
33,362
24,318
9,118
Interest/NOPBT
3.59%
2.58%
1.13%